BCM
MRK icon

Bayesian Capital Management’s Merck MRK Stock Holding History

Bayesian Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47,355
Closed -$4.71M – 834
2024
Q4 		$4.71M Buy
47,355
+3,500
+8% +$361K 0.58% 31
2024
Q3 		$4.98M Buy
43,855
+40,455
+1,190% +$4.81M 0.58% 28
2024
Q2 		$421K Buy
+3,400
New +$438K 0.05% 419
2024
Q1 		– Sell
-6,900
Closed -$752K – 993
2023
Q4 		$752K Buy
+6,900
New +$716K 0.08% 287
2023
Q3 		– Sell
-1,800
Closed -$208K – 873
2023
Q2 		$208K Buy
+1,800
New +$204K 0.02% 633
2022
Q4 		– Sell
-4,972
Closed -$428K – 940
2022
Q3 		$428K Buy
+4,972
New +$444K 0.09% 319
2022
Q2 		– Sell
-43,284
Closed -$3.55M – 970
2022
Q1 		$3.55M Buy
+43,284
New +$3.41M 0.53% 23
2021
Q3 		– Sell
-11,100
Closed -$863K – 483
2021
Q2 		$863K Sell
11,100
-33,754
-75% -$2.51M 0.23% 117
2021
Q1 		$3.3M Buy
44,854
+23,580
+111% +$1.74M 0.76% 26
2020
Q4 		$1.66M Buy
+21,274
New +$1.63M 0.43% 58
2020
Q1 		– Sell
-13,100
Closed -$1.14M – 905
2019
Q4 		$1.14M Buy
+13,100
New +$1.08M 0.19% 156
2019
Q3 		– Sell
-25,886
Closed -$2.07M – 622
2019
Q2 		$2.07M Buy
+25,886
New +$1.98M 0.43% 63
2017
Q4 		– Sell
-35,527
Closed -$2.17M – 657
2017
Q3 		$2.17M Buy
+35,527
New +$2.15M 0.52% 38

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bayesian Capital Management's MRK Position: Q1 2025 in Review

Bayesian Capital Management sold out of Merck (MRK) in Q1 2025, closing a stake of 47,355 shares — an estimated $4.71M sold.

Bayesian Capital Management first reported a position in MRK in Q3 2017 and held it in 13 quarters. The position peaked at $4.98M in Q3 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Bayesian Capital Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 47,355 Merck shares in Q1 2025, an estimated $4.71M.
  • Bayesian Capital Management first reported a position in Merck in Q3 2017 and held it in 13 quarters.
  • Bayesian Capital Management's Merck position peaked at $4.98M in Q3 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.